Document is current
Any future updates will be listed below
-
Authors
Schmuckli-Maurer, Jacqueline
Bindschedler, Annina F.
Wacker, Rahel
Würgler, Oliver M.
Rehmann, Ruth
Lehmberg, Timothy https://orcid.org/0000-0002-3259-8014
Murphy, Leon O.
Nguyen, Thanh N. https://orcid.org/0000-0001-9698-0020
Lazarou, Michael
Monfregola, Jlenia
Ballabio, Andrea https://orcid.org/0000-0003-1381-4604
Heussler, Volker T. https://orcid.org/0000-0001-8028-9825
- License Information
-
More Information
Article History
Received: 15 May 2024
Accepted: 10 November 2024
First Online: 21 November 2024
Competing interests
: The authors declare the following competing interests: L.O.M. and T.L. are employees and shareholders of Casma Therapeutics. A.B. is a co-founder and shareholder of CASMA Therapeutics, Inc, and Advisory board member of Avilar Therapeutics and Amplify Therapeutics. L.O.M. is an author on a patent related to TFEB modulation, in addition. M.L. is a co-founder and member of the scientific advisory board of Automera. Other authors declare no competing interests.
